{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T06:16:28Z","timestamp":1771481788242,"version":"3.50.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,18]]},"DOI":"10.7759\/cureus.103879","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T05:32:46Z","timestamp":1771479166000},"source":"Crossref","is-referenced-by-count":0,"title":["Perihilar Extrahepatic Cholangiocarcinoma With Typical and Atypical Manifestations: Diagnostic Resolution During Autopsy"],"prefix":"10.7759","author":[{"given":"Javier A","family":"Teco-Cortes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tania A","family":"Galindo-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola X","family":"Calder\u00f3n-Navarro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Extrahepatic cholangiocarcinoma","author":"Verbeke SC","year":"2025","unstructured":"Verbeke SC, Zen Y, Basturk O. Extrahepatic cholangiocarcinoma. WHO Classification of Tumours Editorial Board. Digestive System Tumours [Beta version, ahead of print]. International Agency for Research on Cancer, Lyons, France; 2025."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.20517\/2394-5079.2021.130","article-title":"Epidemiology of cholangiocarcinoma","volume":"8","author":"Turati F","year":"2022","unstructured":"Turati F, Bertuccio P, Negri E, Vecchia CL. Epidemiology of cholangiocarcinoma. Hepatoma Res. 2022, 8:19. 10.20517\/2394-5079.2021.130","journal-title":"Hepatoma Res"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.32803","article-title":"Global trends in intrahepatic and extrahepatic cholangiocarcinoma incidence from 1993 to 2012","volume":"126","author":"Florio AA","year":"2020","unstructured":"Florio AA, Ferlay J, Znaor A, et al.. Global trends in intrahepatic and extrahepatic cholangiocarcinoma incidence from 1993 to 2012. Cancer. 2020, 126:2666-78. 10.1002\/cncr.32803","journal-title":"Cancer"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.semdp.2025.150949","article-title":"Extrahepatic cholangiocarcinoma: current concepts in histopathology, immunohistochemistry, and molecular diagnostics","volume":"42","author":"Beyersdorf J","year":"2025","unstructured":"Beyersdorf J, Zhang ML. Extrahepatic cholangiocarcinoma: current concepts in histopathology, immunohistochemistry, and molecular diagnostics. Semin Diagn Pathol. 2025, 42:150949. 10.1016\/j.semdp.2025.150949","journal-title":"Semin Diagn Pathol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2021.03.005","article-title":"An atypical case of acute upper gastrointestinal bleeding","volume":"160","author":"Koutsoumourakis A","year":"2021","unstructured":"Koutsoumourakis A, Stafylidou M, Gagalis A. An atypical case of acute upper gastrointestinal bleeding. Gastroenterology. 2021, 160:2261-3. 10.1053\/j.gastro.2021.03.005","journal-title":"Gastroenterology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.14740\/jmc4253","article-title":"Thrombotic microangiopathy after long-lasting treatment by gemcitabine: description, evolution and treatment of a rare case","volume":"15","author":"Bertin L","year":"2024","unstructured":"Bertin L, Gauthier M, Boullenger F, et al.. Thrombotic microangiopathy after long-lasting treatment by gemcitabine: description, evolution and treatment of a rare case. J Med Cases. 2024, 15:272-7. 10.14740\/jmc4253","journal-title":"J Med Cases"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.63385","article-title":"Gemcitabine-induced thrombotic microangiopathy in a patient with cholangiocarcinoma: an atypical case","volume":"16","author":"Anil V","year":"2024","unstructured":"Anil V, Alhujaily E, Grover D, Santos JP, Kanugula AK, Suleiman M, Singh S. Gemcitabine-induced thrombotic microangiopathy in a patient with cholangiocarcinoma: an atypical case. Cureus. 2024, 16:e63385. 10.7759\/cureus.63385","journal-title":"Cureus"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.11470918","article-title":"Etiology and outcomes of thrombotic microangiopathies","volume":"14","author":"Bayer G","year":"2019","unstructured":"Bayer G, von Tokarski F, Thoreau B, et al.. Etiology and outcomes of thrombotic microangiopathies. Clin J Am Soc Nephrol. 2019, 14:557-66. 10.2215\/CJN.11470918","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25169055","article-title":"The phenomenon of thrombotic microangiopathy in cancer patients","volume":"25","author":"Vorobev A","year":"2024","unstructured":"Vorobev A, Bitsadze V, Yagubova F, et al.. The phenomenon of thrombotic microangiopathy in cancer patients. Int J Mol Sci. 2024, 25:9055. 10.3390\/ijms25169055","journal-title":"Int J Mol Sci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/s13256-019-2195-4","article-title":"Acute kidney injury due to high-output external biliary drainage in a patient with malignant obstructive jaundice: a case report","volume":"13","author":"Jayarajah U","year":"2019","unstructured":"Jayarajah U, Basnayake O, Wijerathne PK, Sivaganesh S. Acute kidney injury due to high-output external biliary drainage in a patient with malignant obstructive jaundice: a case report. J Med Case Rep. 2019, 13:251. 10.1186\/s13256-019-2195-4","journal-title":"J Med Case Rep"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-016-9645-x","article-title":"HER2\/HER3 pathway in biliary tract malignancies; systematic review and meta-analysis: a potential therapeutic target?","volume":"36","author":"Galdy S","year":"2017","unstructured":"Galdy S, Lamarca A, McNamara MG, Hubner RA, Cella CA, Fazio N, Valle JW. HER2\/HER3 pathway in biliary tract malignancies; systematic review and meta-analysis: a potential therapeutic target?. Cancer Metastasis Rev. 2017, 36:141-57. 10.1007\/s10555-016-9645-x","journal-title":"Cancer Metastasis Rev"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2024.113564","article-title":"Revolutionizing anti-HER2 therapies for extrahepatic cholangiocarcinoma and gallbladder cancer: current advancements and future perspectives","volume":"199","author":"Ten Haaft BH","year":"2024","unstructured":"Ten Haaft BH, Pedregal M, Prato J, Kl\u00fcmpen HJ, Moreno V, Lamarca A. Revolutionizing anti-HER2 therapies for extrahepatic cholangiocarcinoma and gallbladder cancer: current advancements and future perspectives. Eur J Cancer. 2024, 199:113564. 10.1016\/j.ejca.2024.113564","journal-title":"Eur J Cancer"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-024-03257-7","article-title":"Genomic characterization and immunotherapy for microsatellite instability-high in cholangiocarcinoma","volume":"22","author":"Yang X","year":"2024","unstructured":"Yang X, Lian B, Zhang N, et al.. Genomic characterization and immunotherapy for microsatellite instability-high in cholangiocarcinoma. BMC Med. 2024, 22:42. 10.1186\/s12916-024-03257-7","journal-title":"BMC Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.02105","article-title":"Efficacy of pembrolizumab in patients with noncolorectal high microsatellite instability\/mismatch repair-deficient cancer: results from the phase II KEYNOTE-158 study","volume":"38","author":"Marabelle A","year":"2020","unstructured":"Marabelle A, Le DT, Ascierto PA, et al.. Efficacy of pembrolizumab in patients with noncolorectal high microsatellite instability\/mismatch repair-deficient cancer: results from the phase II KEYNOTE-158 study. J Clin Oncol. 2020, 38:1-10. 10.1200\/JCO.19.02105","journal-title":"J Clin Oncol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2025.2471226","article-title":"Immunotherapy-induced microsatellite instability status shift in recurrent perihilar cholangiocarcinoma: a case report","volume":"21","author":"Yu H","year":"2025","unstructured":"Yu H, Deng T, Liu H. Immunotherapy-induced microsatellite instability status shift in recurrent perihilar cholangiocarcinoma: a case report. Hum Vaccin Immunother. 2025, 21:2471226. 10.1080\/21645515.2025.2471226","journal-title":"Hum Vaccin Immunother"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-023-02597-9","article-title":"Neuroendocrine component in extrahepatic cholangiocarcinoma is associated with better survival: data from the SEER study","volume":"40","author":"Lv TR","year":"2023","unstructured":"Lv TR, Liu F, Jin YW, Hu HJ, Li FY. Neuroendocrine component in extrahepatic cholangiocarcinoma is associated with better survival: data from the SEER study. Adv Ther. 2023, 40:4032-41. 10.1007\/s12325-023-02597-9","journal-title":"Adv Ther"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.03.008","article-title":"Molecular classification and therapeutic targets in extrahepatic cholangiocarcinoma","volume":"73","author":"Montal R","year":"2020","unstructured":"Montal R, Sia D, Montironi C, et al.. Molecular classification and therapeutic targets in extrahepatic cholangiocarcinoma. J Hepatol. 2020, 73:315-27. 10.1016\/j.jhep.2020.03.008","journal-title":"J Hepatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/466122-perihilar-extrahepatic-cholangiocarcinoma-with-typical-and-atypical-manifestations-diagnostic-resolution-during-autopsy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T05:32:47Z","timestamp":1771479167000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/466122-perihilar-extrahepatic-cholangiocarcinoma-with-typical-and-atypical-manifestations-diagnostic-resolution-during-autopsy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,18]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.103879","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,18]]}}}